EUGOGO activities

Upcoming activities

ESSEN, Germany, March 2026 Teaching course

March 7, 2026

March 8, 2026

View More Info

Singapore, October 2026 Teaching Course

October 22, 2026

October 25, 2026

View More Info

Past events

EUGOGO Global TED Forum 2025

EUGOGO Global TED Forum London 2025: A Resounding Success

The EUGOGO Global TED Forum 2025 in London brought together a record 300+ participants from across the globe, including ophthalmologists, endocrinologists, and other specialists — making it one of EUGOGO’s most successful meetings to date.

Feedback from delegates has been overwhelmingly positive:

  • Over 90% rated the programme excellent for quality, organisation, and scientific relevance.
  • 91% said the Forum fully met their educational goals.
  • 85% plan to apply what they learned directly in clinical practice.

The meeting featured world-class presentations, expert panel discussions, and interactive sessions exploring the latest advances in pathogenesis, targeted therapies, surgical management, and multidisciplinary care.

Participants particularly praised the balance of evidence-based content, opportunities for discussion, and the high scientific integrity of the event.

EUGOGO extends heartfelt thanks to all faculty, participants, and sponsors whose support and contributions made this Forum a true success. Together, we continue to drive progress in understanding and treating Thyroid Eye Disease worldwide. We hope many of you can join us in Essen 7-8 March 2026!

www.eugogo2025.com

EUGOGO Symposium at the SOE Congress
7-9 June 2025

soe2025.soevision.org

soe2025.abstractserver.com/program/#/details/sessions/66

The presentations at the EUGOGO Symposium “Updates on Graves’ Orbitopathy” at SOE Congress in Lisbon 7-9 June 2025 can be seen below:


International Symposium

Final program now available – click to download


Past webinars

12/2022: Early DON – a diagnostic challenge. -Christoph Hintschich (Munich), Stefano Fichera (Catania), Antonella Boschi (Brussels)

01/2023: Graves’ disease and Graves’ orbitopathy in times of COVID pandemic. -Milos Zarkovic (Serbia), Karim Meeran (London), Vickie Lee (London), Colin Dayan (Cardiff)

02/2023: Graves’ orbitopathy and Myasthenia gravis. -Onur Konuk (Ankara), Michael Schittkowski (Göttingen), Justin McKee (Edinburgh)

03/2023: Novel pathophysiological aspects of Graves’ disease/Graves’ orbitopathy. -Michele Marino (Pisa), Laurence du Pasquier (Paris)

04/2023: Ocular hypertension in Graves’ orbitopathy -to treat or not to treat? -Nicole Fichter (Olten), Jelena Juri Mandic (Zagreb), Antonella Boschi (Brussels)

07/2023: Orbital decompression surgery in Graves’ orbitopathy -anatomical/racial differences. -Lelio Baldeschi (Brussels), Gangadhara Sundar (Singapur), Katharina Ponto (Mainz)

10/2023: To correct diplopia in Graves’ orbitopathy -which muscle to choose -Anja Eckstein (Essen), Andrea Papp (Vienna), Nicola Curro (Milan)

12/2023: TSH receptor antibodies -how to measure and interprete. -Maria Cristina Burlacu (Brussels), Rosario Le Moli (Catania), Roland Gärtner (Munich)

04/2024: Medical and surgical outcomes of DON. -Gauthier Kielwasser (Lyon), Romain Manet (Lyon), Nicola Curro (Milan), Claudio Guastella (Milan)